Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%

Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from kidney disease by a fifth, according to a study.

Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of medications that help people shed the pounds, manage blood sugar in patients with type 2 diabetes and prevent heart attacks and strokes in people with heart disease.